TY - JOUR AU - Falcão, Inês AU - Cunha, Leonor PY - 2021/06/30 Y2 - 2024/03/29 TI - Immunotherapy with hymenoptera venom in a child with anaphylaxis JF - NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL JA - REVNEC VL - 30 IS - 2 SE - Case Reports DO - 10.25753/BirthGrowthMJ.v30.i2.19718 UR - https://revistas.rcaap.pt/nascercrescer/article/view/19718 SP - 114-118 AB - <p class="p1">Systemic reactions to <em>hymenoptera</em> venom in childhood are uncommon, comprising less than 1% of cases. The prevalence proves higher in adults, encompassing 0.3−8.9%. Anaphylaxis forms the most severe of all allergic reactions and can be fatal. Specific immunotherapy based on <em>hymenoptera</em> venom is the only treatment that prevents moderate-to-severe systemic reactions. Due to immunotherapy safety and effectiveness, this treatment is indicated during childhood in cases of grade II and III systemic reactions.</p><p class="p1">The authors describe the clinical case of a fourteen-year-old male patient, son of a beekeeper, who was followed in the Allergy and Clinical Immunology Department due to anaphylaxis to <em>hymenoptera</em> venom and was under immunotherapy to <em>Apis mellifera</em> venom since the age of nine, besides complying with measures to evade <em>hymenoptera</em>.</p> ER -